Nephi Stella Selected Research

Nephi Stella Research Topics

Disease

12	Neuroinflammatory Diseases 04/2024 - 08/2003
11	Neoplasms (Cancer) 05/2024 - 08/2007
5	Glioblastoma (Glioblastoma Multiforme) 05/2024 - 01/2016
5	Seizures (Absence Seizure) 01/2023 - 01/2014
5	Epilepsy (Aura) 01/2021 - 01/2014
4	Glioma (Gliomas) 04/2024 - 05/2006
4	Multiple Sclerosis 01/2015 - 03/2004
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015 - 06/2004
4	Astrocytoma (Pilocytic Astrocytoma) 07/2010 - 08/2007
3	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2023 - 10/2017
3	Huntington Disease (Huntington's Disease) 11/2014 - 12/2012
2	Polyploidy 05/2024 - 10/2023
2	Hypothermia 01/2024 - 01/2019
2	Inflammation (Inflammations) 01/2019 - 05/2008
2	Autoimmune Diseases (Autoimmune Disease) 10/2014 - 05/2011
2	Brain Injuries (Brain Injury) 12/2012 - 10/2003
1	Headache (Headaches) 01/2023
1	Hyperalgesia 01/2023
1	Migraine Disorders (Migraine) 01/2023
1	Neuralgia (Stump Neuralgia) 01/2023
1	Febrile Seizures (Febrile Seizure) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 08/2014
1	Polyneuropathies (Polyneuropathy) 12/2013
1	Cataract (Cataracts) 12/2013
1	Ataxia (Dyssynergia) 12/2013
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 12/2013
1	Hearing Loss (Hearing Impairment) 12/2013
1	Weight Loss (Weight Reduction) 12/2012
1	Chronic Pain 05/2011
1	Movement Disorders (Movement Disorder) 02/2010
1	Pain (Aches) 06/2009
1	Body Weight (Weight, Body) 02/2009

Drug/Important Bio-Agent (IBA)

17	CannabinoidsIBA 01/2019 - 03/2004
13	EndocannabinoidsIBA 04/2024 - 08/2003
8	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2023 - 04/2006
4	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 01/2023 - 09/2004
4	HydrolasesIBA 01/2023 - 12/2013
3	Dronabinol (THC)FDA LinkGeneric 01/2024 - 01/2009
3	anandamide (arachidonylethanolamide)IBA 01/2023 - 10/2003
3	CannabidiolIBA 01/2021 - 01/2017
3	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 02/2015 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 12/2009 - 05/2006
3	LipidsIBA 06/2009 - 10/2003
2	Pemetrexed (MTA)FDA Link 05/2024 - 10/2023
2	Temozolomide (Temodar)FDA LinkGeneric 04/2024 - 01/2021
2	Adenosine Triphosphate (ATP)IBA 04/2024 - 09/2004
2	EnzymesIBA 01/2023 - 01/2008
2	Voltage-Gated Sodium ChannelsIBA 01/2021 - 10/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 01/2016
2	Pilocarpine (Ocusert)FDA LinkGeneric 02/2015 - 01/2014
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 02/2015 - 01/2014
2	Muscarinic AgonistsIBA 02/2015 - 01/2014
2	Neuropeptide YIBA 07/2014 - 02/2013
1	RNA (Ribonucleic Acid)IBA 04/2024
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 04/2024
1	Glycerol (Glycerine)FDA LinkGeneric 04/2024
1	Serine (L-Serine)FDA Link 01/2023
1	Monoacylglycerol LipasesIBA 01/2023
1	Clonazepam (Rivotril)FDA LinkGeneric 01/2021
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2021
1	BenzodiazepinesIBA 01/2021
1	GelatinIBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	CarbazolesIBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	indoleIBA 01/2017
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2016
1	Paraoxon (E600)IBA 02/2015
1	Muscarinic M1 ReceptorIBA 02/2015
1	OrganophosphatesIBA 02/2015
1	polyglutamineIBA 11/2014
1	Huntingtin ProteinIBA 11/2014
1	3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA 08/2014
1	Growth Factor ReceptorsIBA 08/2014
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2014
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2014
1	Neutralizing AntibodiesIBA 12/2012
1	Interleukin-6 (Interleukin 6)IBA 12/2012
1	NIR-mbc94IBA 05/2011
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 02/2010
1	PK 11195 (PK11195)IBA 12/2009
1	IRDye 800CWIBA 12/2009
1	NIR-6TIBA 12/2009
1	NIR-conPKIBA 12/2009
1	DAA 1106IBA 12/2009
1	CytokinesIBA 12/2009
1	alpha-SynucleinIBA 06/2009
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 02/2009
1	Cannabinoid Receptor AntagonistsIBA 02/2009
1	(4- amino- 1- (4- chlorobenzyl)- 2- methyl- 5- phenyl- 1H- pyrrol- 3- yl)(phenyl)methanoneIBA 02/2009
1	Indicators and Reagents (Reagents)IBA 05/2008

Therapy/Procedure

10	Therapeutics 01/2021 - 08/2003
2	Radiotherapy 04/2024 - 01/2021
1	Analgesia 01/2024
1	Lasers (Laser) 12/2012
1	Immunomodulation 06/2009